Literature DB >> 3520094

Blood pressure control in normotensive members of hypertensive families.

M G Bianchetti, C Beretta-Piccoli, P Weidmann, C Ferrier.   

Abstract

The cardiovascular pressor responses to a stepwise increase in plasma norepinephrine or angiotensin II concentrations, induced by infusions, were studied in 23 normotensive subjects with a negative and 25 with a positive family history of essential hypertension. The two study groups had a similar mean age (24 +/- 2 (SD) yr), body weight, blood pressure (112/64 +/- 10/7 mmHg), heart rate, plasma and urinary sodium and potassium, and plasma norepinephrine, epinephrine, angiotensin II, renin and aldosterone levels. However, subjects with positive history differed from those with negative history of hypertension by a decreased pressor dose of infused norepinephrine (89 +/- 29 vs. 135 +/- 66 ng/kg/min; P less than 0.005), and a significant (P less than 0.01) shift to the left of the relationship between norepinephrine-induced changes in mean arterial pressure and concomitant changes in plasma norepinephrine. In contrast, the relation between stepwise increasing plasma angiotensin II levels and induced changes in diastolic blood pressure or plasma aldosterone did not differ significantly between the two study groups. These findings delineate a distinct abnormality which may often occur in normotensive offspring of hypertensive families. It is characterized by a selectively disturbed noradrenergic blood pressure control in the presence of a normal angiotensin-mediated blood pressure and aldosterone regulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3520094     DOI: 10.1038/ki.1986.81

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

Review 1.  Heredity and the autonomic nervous system in human hypertension.

Authors:  D T O'Connor; P A Insel; M G Ziegler; V Y Hook; D W Smith; B A Hamilton; P W Taylor; R J Parmer
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

2.  Ketanserin in the treatment of diabetes-associated hypertension.

Authors:  C Beretta-Piccoli
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Twenty four hour intermittent, ambulatory blood pressure monitoring.

Authors:  M Egger; M G Bianchetti; M Gnädinger; R Kobelt; O Oetliker
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

4.  Exogenous insulin augments in healthy volunteers the cardiovascular reactivity to noradrenaline but not to angiotensin II.

Authors:  R O Gans; H J Bilo; W W von Maarschalkerweerd; R J Heine; J J Nauta; A J Donker
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

Review 5.  The pathogenesis of hypertension in obese subjects.

Authors:  P Weidmann; M de Courten; L Boehlen; S Shaw
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  Endothelial function is impaired in the cutaneous microcirculation of adults with psoriasis through reductions in nitric oxide-dependent vasodilation.

Authors:  Billie K Alba; Jody L Greaney; Sara B Ferguson; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-10-20       Impact factor: 4.733

Review 7.  Genetic Variations of Tyrosine Hydroxylase in the Pathogenesis of Hypertension.

Authors:  Yu Ho Lee; Yang Gyun Kim; Ju-Young Moon; Jin Sug Kim; Kyung-Hwan Jeong; Tae Won Lee; Chun-Gyoo Ihm; Sang Ho Lee
Journal:  Electrolyte Blood Press       Date:  2016-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.